Data Dictionary: Belgian Cancer Registry: Difference between revisions

From Beacon
No edit summary
No edit summary
Line 3: Line 3:
Source: [https://kankerregister.org/media/docs/downloads/applications/ManuelWBCRv2.1.pdf]
Source: [https://kankerregister.org/media/docs/downloads/applications/ManuelWBCRv2.1.pdf]


{| class="wikitable"
! Patient's information
|-
! Variables
|-
| Hospital
|-
| Patients' social security number
|-
| Name
|-
| Postal code
|-
| Town
|-
| Country
|-
| Number of the insurer
|-
| Birth date
|-
| Date of death
|-
| Sex
|}


{| class="wikitable"
{| class="wikitable"
! Oncologic Diagnosis
|+ Screening Variables
|-
! Variables
|-
| Incidence date
|-
| Diagnostic method
|-
| OMS score of the diagnosis
|-
| Localization of the primary tumor
|-
| Tumor's laterality
|-
| Tumor's histology
|-
| Degree of diferenciation
|-
| Clinic TNM
|-
| Pathologic TNM
|-
| Other clinic classifications
|-
| Start date of first treatment
|-
| Treatments already received
|-
| Subsequent plan of treatment
|-
| Justification of the registration
|}
 
{| class="wikitable"
! Oncological Follow-up
|-
! Variables
|-
| Incidence date
|-
|-
| Localization of the primitive tumor
| Aspects of Participation and Screening Test Usage
|-
|-
| Tumor's histology
| Aspects of participation
|-
|-
| Occurrence of free interval
| Use of the screening test in the target group 
|-
|-
| Date of first recurrence
| Results obtained and their use (including cancer detection rate, sensitivity, and specificity)
|-
|-
| Plan of subsequent treatment
| Cyto-histopathology register 
|-
|-
| Justification of the follow-up
| Results of further follow-up  
|}
|}

Revision as of 14:03, 30 April 2024

Go back to Belgium page

Source: [1]


Screening Variables
Aspects of Participation and Screening Test Usage
Aspects of participation
Use of the screening test in the target group
Results obtained and their use (including cancer detection rate, sensitivity, and specificity)
Cyto-histopathology register
Results of further follow-up